AU4755200A - Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives - Google Patents

Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives

Info

Publication number
AU4755200A
AU4755200A AU47552/00A AU4755200A AU4755200A AU 4755200 A AU4755200 A AU 4755200A AU 47552/00 A AU47552/00 A AU 47552/00A AU 4755200 A AU4755200 A AU 4755200A AU 4755200 A AU4755200 A AU 4755200A
Authority
AU
Australia
Prior art keywords
pyridofurane
benzofurane
urea
derivatives
cycloalkyl substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47552/00A
Inventor
Gabriele Braunlich
Barbara A. Briggs
William Bullock
Arnel Concepcion
Mazen Es-Sayed
Rudiger Fischer
Mary F Fitzgerald
Burkhard Fugmann
Rolf Henning
Karl-Heinz Schlemmer
Stephan Schneider
Michael Sperzel
Graham Sturton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU4755200A publication Critical patent/AU4755200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU47552/00A 1999-05-17 2000-05-04 Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives Abandoned AU4755200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9911458A GB2350112A (en) 1999-05-17 1999-05-17 Pharmaceutically active cycloalkyl ketones
GB9911458 1999-05-17
PCT/EP2000/004012 WO2000069843A2 (en) 1999-05-17 2000-05-04 Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives

Publications (1)

Publication Number Publication Date
AU4755200A true AU4755200A (en) 2000-12-05

Family

ID=10853625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47552/00A Abandoned AU4755200A (en) 1999-05-17 2000-05-04 Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives

Country Status (3)

Country Link
AU (1) AU4755200A (en)
GB (1) GB2350112A (en)
WO (1) WO2000069843A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
EP1478639A1 (en) 2002-02-22 2004-11-24 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
SG156650A1 (en) 2004-07-16 2009-11-26 Sunesis Pharmaceuticals Inc Thienopyrimidines useful as aurora kinase inhibitors
DE102005013621A1 (en) * 2005-03-24 2006-09-28 Curacyte Discovery Gmbh Substituted 2-aryl (hetaryl) -5-aminothieno [2,3-d] pyrimidine-6-carboxylic acid amides, process for their preparation and use as pharmaceuticals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
GB9504460D0 (en) * 1995-03-06 1995-04-26 Bayer Ag N-(3-Benzofuranyl)urea-derivatives
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas
GB9614718D0 (en) * 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
US6277878B1 (en) * 1998-09-07 2001-08-21 Pfizer Inc Substituted indole compounds as anti-inflammatory and analgesic agents

Also Published As

Publication number Publication date
GB2350112A (en) 2000-11-22
GB9911458D0 (en) 1999-07-14
WO2000069843A3 (en) 2001-02-15
WO2000069843A2 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU4561600A (en) Benzofuranylaminoalcohols
AU4755200A (en) Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives
AU1901801A (en) Glucofuranoses
AU6567400A (en) Substituted 2-imino-thiazolines
AU2582200A (en) Windturbine
AU1915601A (en) Periotome
AU7513400A (en) Hydantoin-racemase
AU7303400A (en) Osseo-distractor
AU4435300A (en) Hula-hoop
AU2197301A (en) Microlamp
AU5416100A (en) Retinoscopes
AU6831100A (en) Substituted heterocyclybenzofuranes
AU7567500A (en) Duckboard

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase